Role of C9orf72 hexanucleotide repeat expansions in ALS/FTD pathogenesis

被引:5
|
作者
Geng, Yanyan [1 ]
Cai, Qixu [2 ]
机构
[1] Xiamen Univ, Affiliated Hosp 1, Xiamen Key Lab Brain Ctr,Sch Med, Dept Neurosurg,Clin Res Inst,Fujian Key Lab Brain, Xiamen, Fujian, Peoples R China
[2] Xiamen Univ, Sch Publ Hlth, State Key Lab Vaccines Infect Dis, Xiamen, Fujian, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
C9orf72; hexanucleotide repeat expansions; G-quadruplex; phase separation; amyotrophic lateral sclerosis; frontotemporal dementia; neurodegenerative diseases; AMYOTROPHIC-LATERAL-SCLEROSIS; GGGGCC REPEAT; RNA FOCI; MOTOR DEFICITS; ANTISENSE TRANSCRIPTS; PHASE-TRANSITIONS; RAN PROTEINS; MOUSE MODEL; QUADRUPLEX; MICE;
D O I
10.3389/fnmol.2024.1322720
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are progressive neurological disorders that share neurodegenerative pathways and features. The most prevalent genetic causes of ALS/FTD is the GGGGCC hexanucleotide repeat expansions in the first intron region of the chromosome 9 open reading frame 72 (C9orf72) gene. In this review, we comprehensively summarize the accumulating evidences elucidating the pathogenic mechanism associated with hexanucleotide repeat expansions in ALS/FTD. These mechanisms encompass the structural polymorphism of DNA and transcribed RNA, the formation of RNA foci via phase separation, and the cytoplasmic accumulation and toxicities of dipeptide-repeat proteins. Additionally, the formation of G-quadruplex structures significantly impairs the expression and normal function of the C9orf72 protein. We also discuss the sequestration of specific RNA binding proteins by GGGGCC RNA, which further contributes to the toxicity of C9orf72 hexanucleotide repeat expansions. The deeper understanding of the pathogenic mechanism of hexanucleotide repeat expansions in ALS/FTD provides multiple potential drug targets for these devastating diseases.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Genetic counseling for FTD/ALS caused by the C9ORF72 hexanucleotide expansion
    Jamie C Fong
    Anna M Karydas
    Jill S Goldman
    Alzheimer's Research & Therapy, 4
  • [22] The ALS/FTD C9ORF72 Hexanucleotide Expansion Disrupts Nucleocytoplasmic Transport
    Zhang, Ke
    Donnelly, Christopher J.
    Haeusler, Aaron R.
    Sattler, Rita
    Wang, Jiou
    Rothstein, Jeffrey D.
    Lloyd, Thomas E.
    ANNALS OF NEUROLOGY, 2014, 76 : S118 - S118
  • [23] C9orf72 Hexanucleotide Repeat Expansions in Clinical Alzheimer Disease
    Harms, Matthew
    Benitez, Bruno A.
    Cairns, Nigel
    Cooper, Breanna
    Cooper, Paul
    Mayo, Kevin
    Carrell, David
    Faber, Kelley
    Williamson, Jennifer
    Bird, Tom
    Diaz-Arrastia, Ramon
    Foroud, Tatiana M.
    Boeve, Bradley F.
    Graff-Radford, Neill R.
    Mayeux, Richard
    Chakraverty, Sumitra
    Goate, Alison M.
    Cruchaga, Carlos
    JAMA NEUROLOGY, 2013, 70 (06) : 736 - 741
  • [24] Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72
    Melissa E. Murray
    Mariely DeJesus-Hernandez
    Nicola J. Rutherford
    Matt Baker
    Ranjan Duara
    Neill R. Graff-Radford
    Zbigniew K. Wszolek
    Tanis J. Ferman
    Keith A. Josephs
    Kevin B. Boylan
    Rosa Rademakers
    Dennis W. Dickson
    Acta Neuropathologica, 2011, 122 : 673 - 690
  • [25] Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72
    Murray, Melissa E.
    DeJesus-Hernandez, Mariely
    Rutherford, Nicola J.
    Baker, Matt
    Duara, Ranjan
    Graff-Radford, Neill R.
    Wszolek, Zbigniew K.
    Ferman, Tanis J.
    Josephs, Keith A.
    Boylan, Kevin B.
    Rademakers, Rosa
    Dickson, Dennis W.
    ACTA NEUROPATHOLOGICA, 2011, 122 (06) : 673 - 690
  • [26] Pathogenesis underlying hexanucleotide repeat expansions in C9orf72 gene in amyotrophic lateral sclerosis
    Chong, Zhao Zhong
    Menkes, Daniel L.
    Souayah, Nizar
    REVIEWS IN THE NEUROSCIENCES, 2024, 35 (01) : 85 - 97
  • [27] C9orf72 hexanucleotide repeat expansion in Turkish ALS patients
    Iskender, C.
    Eken, A. Gundogdu
    Ozoguz, A.
    Akimoto, C.
    Alstermark, H.
    Andersen, P. M.
    Basak, A. N.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 328 - 328
  • [28] C9orf72 hexanucleotide repeat expansion in Turkish ALS patients
    Iskender, C.
    Eken, A. Gundogdu
    Ozoguz, A.
    Akimoto, C.
    Alstermark, H.
    Andersen, P. M.
    Basak, A. N.
    JOURNAL OF NEUROLOGY, 2014, 261 : S222 - S222
  • [29] AAV-9 Mediated Delivery of RNA Targeting Systems Eliminates Hexanucleotide Repeat Expansions in C9ORF72 ALS/FTD Models
    Chew, Jeannie
    Tadokoro, Takahiro
    Geddes, Claire
    Nachtrab, Greg
    Gutierrez, Haydee
    Torres, Ronald
    Li, Na
    Bradford, Hank
    Roth, Daniela
    Gibbs, Dan
    Batra, Ranjan
    Leonard, John
    MOLECULAR THERAPY, 2022, 30 (04) : 570 - 570
  • [30] Frequency and Phenotypes Associated with C9ORF72 Repeat Expansions in French FTD and FTD-ALS Patients
    Le Ber, Isabelle
    Camuzat, Agnes
    Guillot-Noel, Lena
    Habert, Marie-Odile
    Hannequin, Didier
    Seilhean, Danielle
    Lacomblez, Lucette
    Golfier, Veronique
    Puel, Michele
    Deramecourt, Vincent
    Martinaud, Olivier
    Millecamps, Stephanie
    Vercelletto, Martine
    Couratier, Philippe
    Sellal, Francois
    Pasquier, Florence
    Salachas, Francois
    Thomas-Anterion, Catherine
    Didic, Mira
    Pariente, Jeremie
    Blanc, Frederic
    Mondon, Karl
    Michel, Bernard-Francois
    Berger, Eric
    Sauvee, Mathilde
    Campion, Dominique
    Meininger, Vincent
    Duyckaerts, Charles
    Guedj, Eric
    Dubois, Bruno
    Brice, Alexis
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2012, 33 : 82 - 83